ActiveCampaign is First to Launch AI that Acts, Not Just Answers at Spring Innovation Keynote March 18, 2026 New proactive, agent-to-user AI and personalization bring enterprise-grade marketing intelligence to small and mid-size businesses
Reply at NVIDIA GTC: Digital Twins and Physical AI Driving the Next Stage of Industrial Value Creation March 13, 2026 Reply [EXM, STAR: REY] will be present at NVIDIA GTC from 16 to 19 March 2026 in San Jose, California, showcasing how companies can optimise production and logistics processes, scale robotics and sustainably increase industrial performance using digital twin technology and physical AI. The conference is regarded as the most important international meeting point for [...]
Language Weaver Brings Secure AI Translation Directly Into iManage Work Legal Workflows March 10, 2026 Secure multilingual content management gives legal firms competitive edge
Quectel Showcases Advanced mmWave Radar Solutions for Smarter, Safer Vehicles at MWC Barcelona March 2, 2026 Quectel Wireless Solutions, a global end-to-end IoT solutions provider, is showcasing its latest automotive-grade mmWave radar solutions at MWC Barcelona in Spain, highlighting innovations that enhance vehicle safety, convenience and intelligent sensing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260301424839/en/ At the show, Quectel will be showcasing two digital key applications [...]
Bidgely to Showcase AI-Powered Energy Intelligence at IDC European Utilities Xchange March 2, 2026 Keynote speech, executive forums, and roundtables feature strategies for accelerating grid modernization
ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart (N6LS) maintains high levels of viral suppression in long-acting HIV treatment regimen February 25, 2026 94% of adults on stable therapy maintained viral suppression with intravenous lotivibart dosed every four months in combination with long-acting cabotegravir These phase IIb results reinforce lotivibart’s ultra long-acting potential, with the trial progressing to evaluate a twice-yearly intravenous dosing interval
Toshiba Showcases End-to-End Innovations Shaping What’s Next in Retail at EuroShop 2026 February 23, 2026 At EuroShop, Toshiba showcases intelligent, scalable solutions that combine AI, computer vision, and energy-efficient design to transform the future of retail.
New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday February 16, 2026 A new post-hoc analysis from the LIBERTY studies, presented at ECCO 2026, demonstrated that initiating subcutaneous (SC) infliximab (Remsima™ SC) after a treatment interruption following intravenous (IV) infliximab induction helps patients with Crohn’s disease (CD) and ulcerative colitis (UC) recapture and maintain disease control1 The results demonstrated that SC infliximab provides an effective and safe option to regain clinical control after a planned or unplanned treatment interruption More than a total of 30 accepted abstracts including one oral and one digital oral presentation and eight posters, reinforce Celltrion’s commitment to inflammatory bowel disease (IBD) research aimed at enhancing patient outcomes
Allegion to Attend 2026 Barclays Industrial Select Conference February 12, 2026 Allegion plc (NYSE: ALLE) President and CEO John H. Stone will discuss the company’s long-term strategy at the 2026 Barclays Industrial Select Conference on Thursday, Feb. 19. The conference will be held at Loews Miami Beach Hotel. A live listen-only webcast will be accessible via Allegion’s investor website at investor.allegion.com or directly by clicking here. [...]